Health state utilities associated with X-linked retinitis pigmentosa (XLRP).

Saved in:
Bibliographic Details
Title: Health state utilities associated with X-linked retinitis pigmentosa (XLRP).
Authors: Matza LS; Evidera, 929 North Front Street, Wilmington, NC, 28401-3331, USA. louis.matza@thermofisher.com., Li N; Janssen Pharmaceutical K.K, Tokyo, Japan., Stewart KD; Evidera, 929 North Front Street, Wilmington, NC, 28401-3331, USA., Hashim M; Janssen Global Services, LLC, Beerse, Belgium., Denee T; Janssen Europe, Middle East and Africa, Breda, The Netherlands., Pan F; Janssen Global Services, LLC, Raritan, NJ, USA., Zhang Q; Janssen Global Services, LLC, Raritan, NJ, USA., Lee J; Janssen Europe, Middle East and Africa, Copenhagen, Denmark., Michaelides M; UCL Institute of Ophthalmology and Moorfields Eye Hospital, London, UK., Scholl HPN; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.; Pallas Kliniken AG, Pallas Klinik Zürich, Zürich, Switzerland.; European Vision Institute, Basel, Switzerland.
Source: The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2025 Sep; Vol. 26 (7), pp. 1263-1273. Date of Electronic Publication: 2025 Mar 17.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-7601 (Electronic) Linking ISSN: 16187598 NLM ISO Abbreviation: Eur J Health Econ Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1618-7601
DOI:10.1007/s10198-025-01761-y